FDA批准Tepezza治疗甲状腺眼病
2020.01.21
FDA approves first treatment for thyroid eye disease
FDA批准治疗甲状腺眼病的新疗法
Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where ...
|